Wolverine Asset Management LLC Novo Cure LTD Transaction History
Wolverine Asset Management LLC
- $5.25 Billion
- Q2 2025
A detailed history of Wolverine Asset Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Wolverine Asset Management LLC holds 100 shares of NVCR stock, worth $1,139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$1,139
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
79MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$128 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$102 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$62.9 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$59.4 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.2B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...